Squalene lipotoxicity in a lipid droplet-less yeast mutant is linked to plasma membrane dysfunction.
Squalene is a naturally occurring triterpene with wide industrial applications. Due to limited natural resources, production of this valuable lipid in yeast is of high commercial relevance. Accumulation of squalene in yeast can be induced by specific cultivation conditions or genetic modifications. Accumulated squalene is typically stored in lipid droplets (LD), however, it is located in cellular membranes in a Saccharomyces cerevisiae mutant unable to form LD. We induced squalene accumulation in this LD-less mutant by treatment with squalene monooxygenase inhibitor terbinafine to study the effect of squalene on yeast physiology. We present here several lines of evidence that malfunction of the plasma membrane caused by squalene accumulation can be involved in growth arrest and loss of viability in LD-less cells treated by terbinafine. Subinhibitory concentrations of terbinafine increased the sensitivity of LD-less mutant to substances interfering with plasma membrane functions. Impairment of plasma membrane integrity in LD-less cells accumulating squalene was confirmed by disturbed maintenance of membrane potential and by increased plasma membrane permeability to rhodamine 6G. Plasma membrane of LD-less cells treated with terbinafine showed also higher sensitivity to osmotic stress. A causal relationship between these effects and squalene accumulation in terbinafine-treated LD-less cells was confirmed by the rescuing effect of squalene synthase inhibitor zaragozic acid on viability and plasma membrane permeability in terbinafine-treated LD-less cells. Our results support the hypothesis that high squalene levels are toxic to yeast cells with defective LD and that plasma membrane malfunction is involved in the mechanisms of this squalene lipotoxicity.